Table 2 ER stress inhibitor in clinical trials. (TUDCA, Tauroursodeoxycholic acid; UDCA, Ursodeoxycholic acid)
Drug | Mechanism | Disease | Clinical trial | NCT number |
|---|---|---|---|---|
TUDCA | ER stress inhibitor | Type 1 Diabetes | Phase 2 | 02218619 |
TUDCA | ER stress inhibitor | Human Hypertension | Phase 2 | 06025630 |
TUDCA | ER stress inhibitor | cardiovascular disease | Early Phase 1 | 04001647 |
UDCA | ER stress inhibitor | Peritoneal fibrosis | Phase 4 | 02338635 |